Baxter Launches DeviceVue Advanced Asset Tracking System for Sigma Spectrum Infusion System
September 27 2017 - 8:00AM
Business Wire
- Baxter becomes first infusion pump
vendor to provide in-house, end-to-end asset tracking solution for
infusion pumps
- Tagless tracking enables clinicians and
biomedical engineers to find an unused pump quickly by displaying
location and status of every pump
Baxter International Inc. (NYSE: BAX), a leader in innovative
technology for medication delivery, today announced the launch of
DeviceVue, a comprehensive asset tracking solution available
exclusively to hospitals using the Sigma Spectrum Infusion
System. Designed to help enhance clinical and hospital efficiency,
DeviceVue helps enable clinicians and biomedical engineers to
quickly find unused pumps by viewing pump location and status data
from their PC, iPad® or iPhone®. With DeviceVue, Baxter is the
first and only smart infusion pump manufacturer to offer a tagless,
end-to-end asset tracking application.
“Healthcare leaders today are required to deliver clinical and
financial return on every dollar spent,” said Scott Luce, general
manager, U.S. Hospital Products, Baxter. “Baxter is committed to
continually enhancing the award-winning Sigma Spectrum
Infusion System through technologies like DeviceVue that drive
operational efficiencies and help facilities maximize clinical
value.”
In place of the cost and labor associated with purchasing and
installing external radio frequency identification (RFID) tags,
DeviceVue receives a signal from the pump’s wireless radio that
provides location data, whether the pump is in use, and the status
of the pump battery, wireless network connection, and drug library.
This data is sent in near real-time to the DeviceVue PC or mobile
application.
DeviceVue is currently in use at multiple health systems across
the country, including Mississippi Baptist Medical Center in
Jackson, Miss., a 564-bed, Magnet®-recognized facility. The Magnet
designation represents the highest distinction for nursing
excellence and patient care.
In addition to asset tracking, DeviceVue’s utilization reporting
can help hospitals reduce costs by ensuring as many pumps as
possible are put to use, while the ability to search for specific
pumps by serial number can help biomedical engineers dramatically
reduce the amount of time required to perform preventive
maintenance.
For more information on the Sigma Spectrum Infusion
System, please visit www.sigmapumps.com.
About Sigma Spectrum Infusion System
Sigma Spectrum’s hardware works in concert with the
pump’s software to encourage use of innovative features that are
designed to help enhance patient safety and clinician efficiency.
For example, the pumps automatically default to the installed drug
library without requiring clinicians to take extra steps to
“opt-in,” and drug library updates can be delivered wirelessly to
pumps in the facility without interrupting clinical workflow.
Sigma Spectrum is the only pump to include a built-in
Dose/Rate Change Error Prevention Feature, which helps clinicians
protect high-risk infusions during titrations, and allows
pharmacists to customize dose change limits for individual drugs.
Sigma Spectrum also includes features like: integration with
electronic health record (EHR) systems—including Cerner® and
Epic®—to help streamline clinical workflow and improve accuracy of
IV infusion documentation; DeviceVue, a tagless, end-to-end asset
tracking solution that can help provide a significant boost to both
clinical and operational efficiency; enhanced data analytics and
use of single set technology that can help yield up to 53 percent
cost savings in IV tubing sets and 30 percent reduction in IV
tubing use.1
DeviceVue will work with any V8 and V6 Sigma Spectrum
infusion pump that has a wireless radio and Master Drug Library
v6.5.6 or later.Pumps must have at least 25% charge in order to
continue providing data to DeviceVue.Sigma Spectrum Infusion
System is Rx Only. For the safe and proper use of this
device, refer to the appropriate operator’s manuals.
About Baxter
Baxter provides a broad portfolio of essential renal and
hospital products, including home, acute and in-center dialysis;
sterile IV solutions; infusion systems and devices; parenteral
nutrition; surgery products and anesthetics; and pharmacy
automation, software and services. The company’s global footprint
and the critical nature of its products and services play a key
role in expanding access to healthcare in emerging and developed
countries. Baxter’s employees worldwide are building upon the
company’s rich heritage of medical breakthroughs to advance the
next generation of healthcare innovations that enable patient
care.
This release includes forward-looking statements concerning
Baxter's DeviceVue and Sigma Spectrum Infusion System and related
performance data, including anticipated benefits associated with
their use. The statements are based on assumptions about many
important factors, including the following, which could cause
actual results to differ materially from those in the
forward-looking statements: satisfaction of regulatory and other
requirements; actions of regulatory bodies and other governmental
authorities; demand for and market acceptance of new and existing
products; product development risks; the impact of competitive
products and pricing; product quality, manufacturing or supply
issues; patient safety issues; breaches or failures of the
company’s information technology systems; changes in law and
regulations; and other risks identified in Baxter's most recent
filing on Form 10-K and other SEC filings, all of which are
available on Baxter's website. Baxter does not undertake to update
its forward-looking statements.
Baxter and Sigma Spectrum are trademarks of Baxter
International Inc.
iPad and iPhone are registered trademarks of Apple Inc.
The Magnet Recognition Program®, ANCC Magnet Recognition®,
Magnet®, ANCC National Magnet Conference®, and Journey to Magnet
Excellence® names and logos are registered trademarks of the
American Nurses Credentialing Center. All rights reserved.
Cerner is a registered trademark of Cerner Corporation and/or
its subsidiaries.
Epic is a registered trademark of Epic Systems Corporation in
the United States and/or in other countries.
1 Data on File. Baxter Healthcare Corporation. Total cost of
ownership standard set technology inventory and cost reduction data
2011- 2013. *Data provided by these facilities. Baxter makes no
guarantee of cost savings.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170927005618/en/
Baxter International Inc.Media ContactEric Tatro, (224)
948-5353media@baxter.comorInvestor ContactClare Trachtman,
(224) 948-3085
Baxter (NYSE:BAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Baxter (NYSE:BAX)
Historical Stock Chart
From Apr 2023 to Apr 2024